Investors

Novakand Pharma’s financial instrument has been traded on the Nasdaq First North Premier up until April 13, 2026. The company is currently not listed on a stock exchange or other approved marketplace.

Press Releases

Press Release
Novakand Pharma to hold Extraordinary General Meeting to decide on future business direction – Comments from the board of directors
31 March 2026
Press Release
Novakand’s Board of Directors proposes new business direction and relisting to be presented at Extraordinary General Meeting
2 March 2026
Press Release
The board evaluates Novakand Pharma’s options after the decision not to execute the planned reverse take over of SVF Vaccines
25 February 2026